M&R Capital Management Inc Pfizer Inc Transaction History

M&R Capital Management Inc

$445 Million
Q3 2024

A detailed history of M&R Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, M&R Capital Management Inc holds 32,296 shares of PFE stock, worth $847,447. This represents 0.21% of its overall portfolio holdings.

Number of Shares

32,296

Previous 33,033 2.23%

Holding current value

$847,447

Previous $924,000 1.08%

% of portfolio

0.21%

Previous 0.22%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 02, 2024	SELL	$27.7 - $31.39 $20,414 - $23,134	-737 Reduced 2.23%	32,296 $934,000
Q2 2024 Jul 02, 2024	SELL	$25.26 - $29.6 $88,940 - $104,221	-3,521 Reduced 9.63%	33,033 $924,000
Q1 2024 Apr 02, 2024	SELL	$25.89 - $29.73 $102,809 - $118,057	-3,971 Reduced 9.8%	36,554 $1.01 Million
Q4 2023 Jan 02, 2024	SELL	$26.13 - $33.94 $77,658 - $100,869	-2,972 Reduced 6.83%	40,525 $1.17 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $27,083 - $31,658	-844 Reduced 1.9%	43,497 $1.44 Million
Q2 2023 Jul 05, 2023	SELL	$36.12 - $41.79 $1,805 - $2,089	-50 Reduced 0.11%	44,341 $1.63 Million
Q1 2023 Apr 03, 2023	SELL	$39.39 - $51.28 $41,280 - $53,741	-1,048 Reduced 2.31%	44,391 $1.81 Million
Q4 2022 Jan 11, 2023	SELL	$41.75 - $54.5 $13,067 - $17,058	-313 Reduced 0.68%	45,439 $0
Q3 2022 Oct 03, 2022	BUY	$43.76 - $53.42 $3,325 - $4,059	76 Added 0.17%	45,752 $2 Million
Q2 2022 Jul 05, 2022	SELL	$46.53 - $55.17 $16,518 - $19,585	-355 Reduced 0.77%	45,676 $2.39 Million
Q1 2022 Apr 04, 2022	BUY	$45.75 - $56.69 $189,130 - $234,356	4,134 Added 9.87%	46,031 $2.38 Million
Q4 2021 Jan 07, 2022	BUY	$41.32 - $61.25 $216,103 - $320,337	5,230 Added 14.26%	41,897 $2.47 Million
Q3 2021 Oct 05, 2021	BUY	$39.25 - $50.42 $7,850 - $10,084	200 Added 0.55%	36,667 $1.58 Million
Q2 2021 Jul 02, 2021	BUY	$35.91 - $40.68 $59,036 - $66,877	1,644 Added 4.72%	36,467 $1.43 Million
Q1 2021 Apr 01, 2021	SELL	$33.49 - $37.77 $433,159 - $488,517	-12,934 Reduced 27.08%	34,823 $1.26 Million
Q4 2020 Jan 05, 2021	SELL	$33.47 - $42.56 $155,702 - $197,989	-4,652 Reduced 8.88%	47,757 $1.76 Million
Q3 2020 Oct 01, 2020	BUY	$31.75 - $37.25 $3,206 - $3,762	101 Added 0.19%	52,409 $1.92 Million
Q2 2020 Jul 01, 2020	SELL	$30.12 - $36.54 $773,331 - $938,164	-25,675 Reduced 32.92%	52,308 $1.71 Million
Q1 2020 Apr 02, 2020	SELL	$27.03 - $38.62 $835,362 - $1.19 Million	-30,905 Reduced 28.38%	77,983 $2.55 Million
Q4 2019 Jan 07, 2020	SELL	$32.92 - $37.36 $336,672 - $382,080	-10,227 Reduced 8.59%	108,888 $4.27 Million
Q3 2019 Oct 02, 2019	SELL	$32.49 - $42.13 $172,651 - $223,878	-5,314 Reduced 4.27%	119,115 $4.28 Million
Q2 2019 Jul 24, 2019	SELL	$36.98 - $41.52 $9,429 - $10,587	-255 Reduced 0.2%	124,429 $5.39 Million
Q1 2019 Apr 29, 2019	BUY	$37.5 - $41.2 $275,812 - $303,026	7,355 Added 6.27%	124,684 $4.98 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $13,426 - $15,307	349 Added 0.3%	117,329 $5.12 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $16,614 - $20,152	-482 Reduced 0.41%	116,980 $5.16 Million
Q2 2018 Aug 08, 2018	SELL	$32.98 - $35.16 $95,048 - $101,331	-2,882 Reduced 2.39%	117,462 $4.26 Million
Q1 2018 May 11, 2018	SELL	$31.91 - $37.02 $26,612 - $30,874	-834 Reduced 0.69%	120,344 $4.27 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $117,441 - $124,608	3,531 Added 3.0%	121,178 $4.39 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $77,004 - $84,828	-2,484 Reduced 2.07%	117,647 $4.2 Million
Q2 2017 Aug 15, 2017	BUY	N/A	120,131	120,131 $3.99 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&R Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on M&R Capital Management Inc with notifications on news.

Account

M&R Capital Management Inc Pfizer Inc Transaction History